Welcome to our dedicated page for Clorox Co Del SEC filings (Ticker: CLX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From the bleach that powers hospital disinfection to Hidden Valley salad dressing on kitchen tables, Clorox’s portfolio touches nearly every room of the home—and that breadth shows up in its SEC paperwork. The 10-K alone tracks raw-material inflation on sodium hypochlorite, charcoal volumes at Kingsford, and plastic-reduction targets across Brita and Glad. If you’ve ever searched Google for “Clorox SEC filings explained simply” or wondered where to locate a “Clorox insider trading Form 4 transactions” alert, you’re in the right place.
Stock Titan’s AI decodes each release the moment it hits EDGAR. Our real-time engine flags “Clorox Form 4 insider transactions real-time,” pulls margin commentary from every “Clorox quarterly earnings report 10-Q filing,” and distills risk-factor changes so you can grasp them in minutes. Need to understand the ESG footnotes? Click the “Clorox annual report 10-K simplified” summary. Curious about board pay? The platform links directly to the “Clorox proxy statement executive compensation” tables and highlights year-over-year shifts.
Investors use these insights to monitor bleach demand during flu season, compare segment profits between Household and Lifestyle units, and track “Clorox 8-K material events explained”—from factory outages to strategic divestitures. Whether you’re screening “Clorox earnings report filing analysis” for revenue trends or verifying “Clorox executive stock transactions Form 4” before making a move, Stock Titan equips you with AI-powered summaries, real-time filing updates, and comprehensive coverage of every form—saving you hours of document review.
Christopher J. Williams, a director of Clorox Co. (CLX), reported two grants of Deferred Stock Units (DSUs) on a Form 4. On 08/29/2025 he received 199.8083 DSUs through dividend reinvestment; on 09/30/2025 he received 212.8954 DSUs in lieu of quarterly director fees. The DSUs are 1-for-1 and will be settled in Clorox common stock upon the reporting person’s retirement or other termination of director service. Following these transactions, the reporting person beneficially owns 19,458.9483 shares (reported as 19,246.0529 before the 09/30/2025 grant).
Russell J. Weiner, a director of Clorox Co. (CLX), received additional deferred stock units (DSUs) under the company's Independent Directors' Deferred Compensation Plan. On 08/29/2025 he was credited with 156.7731 DSUs via dividend reinvestment and on 09/30/2025 he received 253.4469 DSUs in lieu of quarterly director fees. The reported DSUs will be settled 100% in Clorox common stock when the reporting person retires or otherwise terminates service as a director. After these transactions the reporting person beneficially owned 15,354.2406 DSUs (expressed as common stock equivalents) held directly.
Matthew J. Shattock, a director of Clorox Co. (CLX), reported two grants of Deferred Stock Units (DSUs) that increase his notional holdings. On 08/29/2025 he received 172.9087 DSUs through dividend reinvestment, and on 09/30/2025 he received 415.6529 DSUs in lieu of quarterly director fees.
The report shows DSUs convert on a 1-for-1 basis into common stock at the director's retirement or termination and that the total DSUs after the September grant equal 17,070.6618 shares. Both grants are reported as direct beneficial ownership and have a $0.00 per-unit price because they are deferred compensation awards.
Clorox director Stephanie Plaines reported two grants of Deferred Stock Units (DSUs) that increase her beneficial ownership. On 08/29/2025 she received 53.9884 DSUs through dividend reinvestment, and on 09/30/2025 she received 212.8954 DSUs in lieu of quarterly director fees. The filing shows the DSUs will be settled 100% in Clorox common stock upon the reporting person’s retirement or other termination, and total reported beneficial ownership after the transactions is 5,413.1984 shares (previously 5,200.303).
Spencer C. Fleischer, a director of Clorox Co. (CLX), reported two acquisitions of deferred stock units under the board’s deferred compensation plan. On 08/29/2025 he received 192.9623 deferred stock units through dividend reinvestment and on 09/30/2025 he received 212.8954 units in lieu of quarterly director fees. The filing states the deferred stock units will be settled 1-for-1 in Clorox common stock upon the reporting person’s retirement or termination. Following the reported transactions, the filing shows total beneficial ownership of 18,799.5242 common shares.
Pierre R. Breber, a Director of Clorox Co. (CLX), reported transactions showing continued ownership and receipt of deferred compensation units. The filing shows indirect ownership of 9,000 shares through a family trust. On 08/29/2025 he acquired 502.2399 deferred stock units via dividend reinvestment under the Independent Directors' Deferred Compensation Plan, and on 09/30/2025 he received 263.5848 deferred stock units in lieu of quarterly director fees. The report states the deferred stock units are 1-for-1 and "will be settled 100% in Clorox stock" upon the reporting person's retirement or other termination of service as a Director. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
Laurene E. Peck, Vice President, Chief Accounting Officer & Corporate Controller of Clorox Co. (CLX), reported an acquisition on 09/16/2025 of 1,441 shares of common stock via restricted stock units at an attributable price of $124.85 per share. After the transaction Ms. Peck beneficially owned 5,821 shares directly and 100 shares indirectly through a trust of a parent. The restricted stock units vest in four equal installments on October 5 of 2026, 2027, 2028 and 2029. The Form 4 was signed by an attorney-in-fact on 09/18/2025.
Stacey Grier, EVP & Executive Chief of Staff at The Clorox Company (CLX), reported an acquisition of 3,364 restricted stock units on 09/16/2025. The Form 4 shows the units were recorded at a price of $124.85 and, after the transaction, Ms. Grier beneficially owned 23,190 shares. The restricted stock units vest in four equal installments, with one-quarter vesting on each of October 5, 2026, 2027, 2028 and 2029. The filing was signed by an attorney-in-fact on 09/18/2025.
Angela C. Hilt, Executive Vice President and Chief Legal Officer of The Clorox Company (CLX), reported an acquisition of 7,048 shares of Clorox common stock on 09/16/2025 at a reported price of $124.85 per share. After the reported transaction she beneficially owns 26,881 shares directly. The filing also discloses indirect ownership of 609.663 shares held via the company 401(k) plan. The acquired shares are described as Restricted Stock Units that will vest in four equal installments on October 5 of 2026, 2027, 2028 and 2029.
Marriner Kirsten, Executive Vice President and Chief Administrative Officer of Clorox Co. (CLX), reported an acquisition on 09/16/2025 of 7,689 shares of Clorox common stock at an average price of $124.85 per share, increasing her direct beneficial ownership to 33,994 shares. The filing is a single-person Form 4 signed by an attorney-in-fact on 09/18/2025. The report also discloses that the related Restricted Stock Units will vest in four equal installments, with one-quarter vesting on each of October 5, 2026, 2027, 2028, and 2029.
FAQ
What is the current stock price of Clorox Co Del (CLX)?
What is the market cap of Clorox Co Del (CLX)?
